Conduit Pharmaceuticals Inc (NASDAQ: CDT) is -97.21% lower on its value in year-to-date trading and has touched a low of $0.11 and a high of $12.89 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CDT stock was last observed hovering at around $0.13 in the last trading session, with the day’s loss setting it 0.0%.
Currently trading at $0.13, the stock is -4.27% and -26.46% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.77 million and changing 0.71% at the moment leaves the stock -94.63% off its SMA200. CDT registered -98.78% loss for a year compared to 6-month loss of -96.28%. The firm has a 50-day simple moving average (SMA 50) of $0.17012 and a 200-day simple moving average (SMA200) of $2.34629.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -21.67% gain in the last 1 month and extending the period to 3 months gives it a -88.03%, and is -6.14% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.12% over the week and 9.44% over the month.
Conduit Pharmaceuticals Inc (CDT) has around 7 employees, a market worth around $12.18M and $0.00M in sales. Distance from 52-week low is 12.70% and -99.02% from its 52-week high.
43.0 institutions hold shares in Conduit Pharmaceuticals Inc (CDT), with institutional investors hold 10.31% of the company’s shares. The shares outstanding are 73.83M, and float is at 39.83M with Short Float at 2.69%. Institutions hold 3.13% of the Float.
Conduit Pharmaceuticals Inc (CDT) Insider Activity
The most recent transaction is an insider sale by Regan Andrew, the company’s Director. SEC filings show that Regan Andrew sold 10,244,392 shares of the company’s common stock on Jul 16 ’24 at a price of $0.32 per share for a total of $3.25 million. Following the sale, the insider now owns 1.69 million shares.
Conduit Pharmaceuticals Inc disclosed in a document filed with the SEC on Jul 17 ’24 that Regan Andrew (Director) sold a total of 1,514,100 shares of the company’s common stock. The trade occurred on Jul 17 ’24 and was made at $0.26 per share for $0.39 million. Following the transaction, the insider now directly holds 0.18 million shares of the CDT stock.
Still, SEC filings show that on Jul 12 ’24, Regan Andrew (Director) disposed off 1,389,820 shares at an average price of $0.25 for $0.34 million. The insider now directly holds 12,941,319 shares of Conduit Pharmaceuticals Inc (CDT).
